Hepatitis C infection and apoptosis in hepatocellular Carcinoma

Pakistan Journal of Biological Sciences

Volumn 12, Issue 10, 2009, Pages 804-808

  Alkahtani, Saad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Apoptosis; Fas expression; Hepatitis; Liver enzyme

Indexed keywords

ALPHA FETOPROTEIN; FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; KINETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPHA-FETOPROTEINS; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INFLAMMATION; KINETICS; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS;

EID: 67651109092     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.804.808     Document Type: Article

References (23)

1. Ali, C., E. Ariel, H. Feldstein, N. Higuchi, A. Werneburg, S. Grambihler and J. Gregory, 2003. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology, 38:1188-1198.
2. Ayman Abdo, A., M. Badr Al-Jarallah, M. Faisal Sanai, S. Ahmed Hersi and A. Khalid et al., 2006. Hepatitis B genotype: Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J. Gastroenterol., 12:7019-7024.
3. Boom, R., C. J. A. Sol and D. Wertheim-Van, 1990. Rapid purification of ribosomal RNAs from neutral agarose gels. Nucl. Acids Res., 18:2195-2195.
4. Clarke, A. and R. Kulasegaram, 2006. Hepatitis C transmission Where are we now? Int. J. STD AIDS, 17:74-80.
5. Ferrante, A. and Y. Thong, 1980. Optimal condition of simultaneous purification of mononuclear and polymorphonudear leukoytes from human blood by the Hypaque-Ficoll method. J. Immunol. Meth, 36:109-117.
6. Higuchi, H. and G. Gores, 2003. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am. J. Physiol. Gastrointest. Liver Physiol., 284:734-738.
7. Iio, S., N. Hayashi and E. Mita, 1998. Serum levels of soluble Fas antigen in chronic hepatitis C patients. J. Hepatol., 29:517-523.
8. 8+ T cells is enhanced by co-culture with hepatocytes expressing Hepatitis C Virus (HCV) structural proteins through Fas-L induction. Virology, 346:363-372.
9. Klin, Z., 1970. Kinetic determination of Glutamate pyruvate transaminase and Glutamate oxaloacetate transaminase-IFCC version without pyridoxal phosphate activation. Biochemistry, 8:658-658.
10. Kondo, T., T. Suda, H. Fukuyama, M. Adachi and S. Nagata, 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med., 3:409-413.
11. Li, M. S., Q. L. Ma, Q. Chen and X. H. Liu, 2005. Alphafetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells. World J. Gastroenterol., 11:2564-2569.
12. Lotfy, M., I. M. El-Kady, W. A. Nasif, A. E. El-Kenawy and G. Badra, 2006. Distinct serum immunoglobulins pattern in Egyptian patients with chronic HCV infection analyzed by nephelometry. J. Immunoassay Immunochem., 27:103-114.
13. Moriyama, M., H. Matsumura, A. Watanabe, H. Nakamura and Y. Arakawa et al, 2004. Detection of serum and intrahepatic KL-6 in anti-HCV positive patients with hepatocellular carcinoma. Hepatol. Res., 30:24-33.
14. Neuman, M. G., J. P. Benhamou and P. Marcellin, 2007. Cytokine-chemokine and apoptotic signatures in patients with hepatitis C. Translational Res., 149:126-136.
15. Nonyasu, T., T. Yoshihiro and S. Motohiro, 2000. Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br. J. Heamatol, 110:89-97.
16. Pelli, N., A. Floreani and F. Tone, 2007. Soluble apoptosis molecules in primary biliary cirrhosis: Analysis and commitment of the Fas and tumour necrosis factorrelated apoptosis-inducing ligand systems in comparisons with chronic hepatitis C. Clin. Exp. Immumol., 148:85-89.
17. Seeff, L. and J. Hoofnagle, 2006. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene, 25:3771-3777.
18. Smith, C. A., T. Farrah and R. G. Goodwin, 1994. The TNF-receptor superfamily of cellular and viral proteins: Activation, co-stimulation and death. Cell, 76:959-962.
19. Spengler, U. and J. Nattermann, 2007. Immunopathogenesis in hepatitis C virus cirrhosis. Clin. Sci. (Lond.), 112:141-155.
20. Tarao, K., Y. Rino and S. Ohkawa, 1999. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer, 86:589-595.
21. Walczak, H and P. Krammer, 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res., 256:58-66.
22. Williams, J. F., 1998. Optimization strategies for the polymerase chain reaction. Biotechniques, 7:762-769.
23. Wong, T. and S. Lee, 2006. Hepatitis C: A review for primary care physicians. Can. Med. Assoc. J., 174:647-647.